Human epidermal growth factor receptor 2-positive (HER2+) tumors exhibited the highest level of radioresistance, whereas patients with triple-negative breast cancer (TNBC) derived the greatest reduction in breast cancer-specific mortality from radiotherapy 2. This evidence concerns the gene ERBB2 and breast cancer.